Oncolink Features

Find My Cancer Drug

Librera OncoLink / Repaso de Diarios / Cáncer de Testículo

Cáncer de Testículo

MRC TE19: Radiotherapy versus single-dose carboplatin in adjuvant treatment of Stage I Seminoma: a randomised (sic) trial Author: Oliver RTD et al. Source: Lancet 366: 293-300. Background The standard treatments for stage I seminoma are not ideal. Radiation carries the risk of second malignancy in these young patients, the majority of whom would remain free of...
Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial Reviewers: Kenneth Blank, MDSource: Journal of Clinical Oncology April 1999 Vol 17 No 4 p1146IntroductionThe adjuvant treatment of stage I testicular cancer is controversial. After surgical removal of the involved testis, treatment options include...
Para-aortic irradiation only appears to be adequate treatment for the patients with stage I seminoma of the testis Reviewers: Kenneth Blank, MD and Leonard Farber, MD Source: International Journal of Radiation Oncology, Biology and Physics, 15 January 1998, Volume 40 Number 2 455The most common tumors in men between the ages of 15 and 35 years of age are...
Pre-natal and Peri-natal Exposures and Risk of Testicular Germ-cell Cancer Reviewers: Li Liu, MD Source: International Journal of Cancer, Volume 87:438-443, (August) 2000Précis: In utero estrogen exposure is linked to testicular germ-cell cancerIntroductionThe causes of testicular cancer are unknown, but both...
Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer Reviewers: Leonard A. Farber, M.D. and John Chang, M.D. Source: Journal of the National Cancer Institute 1997; 89:1429-39Testicular cancer has been treated with a variety of modalities including radiotherapy and chemotherapy, with a 5-year...
Treatment-Associated Leukemia Following Testicular Cancer Reviewers: Li Liu, MD Source: Journal of the National Cancer Institute, Volume 92(14): 1165-1171 (July) 2000Précis: Testicular cancer treatment: survival advantage far exceeds the risk of treatment-induced leukemiaIntroductionThe...

OncoLink I wish u knew...

Dr. Vapiwala discusses the Affordable Care Act and access to healthcare. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews

Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement